Methotrexate Versus Apremilast for Pruritus in Psoriasis

Clinical trial NCT07432386 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07432386
Sponsor: Zarmeen Khawar
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Pruritus

Start date: 2026-05-14
Primary completion: 2026-10-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.